RepliCel Life Sciences Company
RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.
Technology:
Stem cell therapy
Industry:
Cell Therapy, Public
Headquarters:
Vancouver, British Columbia, Canada
Founded Date:
2010-01-01
Employees Number:
1-10
Funding Status:
IPO
Investors Number:
2
Total Funding:
8566798
Estimated Revenue:
Less than $1M
Last Funding Date:
2021-01-25
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership